Return to program book search

Session Information

FRM F110 - Systemic Immunosuppression in Dermatology: Pre-Treatment Work up, Dosing, Monitoring and Prevention of Adverse Effects

Open admission to eligible categories, no tuition or ticket

Subject:

Date: Monday, March 24

CME Credits: 2.00

Location: Room 705/707

Time: 10:00 AM - 12:00 PM

Director: Nicole Fett, MD, FAAD - Handout

Speakers:
  • Joseph Merola, MD, MSc, FAAD
  • Junko Takeshita, MD, PhD, FAAD
  • David A. Wetter, MD, FAAD - Handout

Learning Objectives:
Following this course, the attendee should be able to:

  • Complete the appropriate laboratory evaluation prior to providing systemic immunosuppressants
  • Provide the appropriate vaccines prior to starting systemic immunosuppressants
  • Describe the most common adverse effects of systemic immunosuppressants

Description:
Our session will cover special topics in systemic immunosuppressants. We will discuss the current recommendations on the prevention of glucocorticoid induced osteoporosis and dosing of bisphosphonates, pre-treatment vaccination recommendations, the REMs program for mycophenolate mofetil, the risks of infection and cancer with biologic and non-biologic agents, a therapeutic ladder for antimalarial use and the risk of retinal toxicity, and the use of systemic immunosuppressants in patients with chronic infections such as HIV and hepatitis B and C.

Schedule:

Monday, March 24
10:00 AMPart 1. Prevention of Glucocorticoid-Induced Osteoporosis. Part 2. Mycophenolate Mofetil: Pre-Treatment Vaccines, REMs, Dosing, Adverse Events / Dr. Fett
10:40 AMTNF-alpha Inhibitors: Use in Patients with HIV and Hepatitis B and C, Vaccine Use, Risk of Infections and Malignancy / Dr. Takeshita
11:10 AMAntimalarials: A Therapeutic Ladder, Risk of Retinal Toxicity and Retinal Screening Recommendations / Dr. Merola
11:30 AMMethotrexate and Azathioprine: Pre-Treatment Labs, Dosing, Monitoring and Concurrent Medications / Dr. Wetter